Work

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Archives of Internal Medicine

DOI: 10.1001/archinte.166.15.1571

Author: Cheryl Oncken

Institution: UConn Health

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2113308458

FWCI: 41.8

Cites: 14

Cited by: 384

Related to: 10